Suven Life Sciences Ltd’s net profit increased significantly to Rs 45 crore in the second quarter ended September 30, 2013.
It had posted a Rs 6.48-crore profit in the corresponding quarter of the previous fiscal. The total revenue of the Hyderabad-based company increased to Rs 151 crore (Rs 50 cr).
New product
The growth in profit and revenue was a result of a new product, in addition to two products commercialised during the first quarter, the company said in a release issued on Monday.
The earnings per share increased to Rs 3.90 (Rs 0.56). Suven has spent 9.8 per cent of its revenue on research and development during the half-year ended September.
It had 607 product patents for 18 inventions and 35 process patents.
Suven’s scrip gained 12.14 per cent and was trading at Rs 74.35 by noon on the BSE on Monday.